Cargando…
The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
The mTOR pathway plays a central role in many cellular processes, such as cellular growth, protein synthesis, glucose, and lipid metabolism. Aberrant regulation of mTOR is a hallmark of many cancers, including hematological malignancies. mTOR inhibitors, such as Rapamycin and Rapamycin analogs (Rapa...
Autores principales: | Feng, Yimei, Chen, Xiaoli, Cassady, Kaniel, Zou, Zhongmin, Yang, Shijie, Wang, Zheng, Zhang, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821787/ https://www.ncbi.nlm.nih.gov/pubmed/33489922 http://dx.doi.org/10.3389/fonc.2020.611690 |
Ejemplares similares
-
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
por: Feng, Yimei, et al.
Publicado: (2019) -
The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety
por: Chen, Xiaoli, et al.
Publicado: (2021) -
mTOR signaling in glioblastoma: lessons learned from bench to bedside
por: Akhavan, David, et al.
Publicado: (2010) -
Case Report: PD-1 Blockade Combined Autologous Hematopoietic Stem Cell Transplantation With Modified BEAM Regimen Containing High-Dose Cytarabine to Treat R/R Hodgkin's Lymphoma
por: Wang, Xiaoqi, et al.
Publicado: (2021) -
Regulation of the mTOR signaling pathway: from laboratory bench to bedside and back again
por: Abraham, Robert T
Publicado: (2009)